[go: up one dir, main page]

NO953931L - Chinolon- og naftyridonkarboksylsyrederivater - Google Patents

Chinolon- og naftyridonkarboksylsyrederivater

Info

Publication number
NO953931L
NO953931L NO953931A NO953931A NO953931L NO 953931 L NO953931 L NO 953931L NO 953931 A NO953931 A NO 953931A NO 953931 A NO953931 A NO 953931A NO 953931 L NO953931 L NO 953931L
Authority
NO
Norway
Prior art keywords
halogen
ome
opt
substd
formula
Prior art date
Application number
NO953931A
Other languages
English (en)
Other versions
NO953931D0 (no
NO307514B1 (no
Inventor
Uwe Petersen
Thomas Schenke
Klaus-Dieter Bremm
Rainer Endermann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO953931D0 publication Critical patent/NO953931D0/no
Publication of NO953931L publication Critical patent/NO953931L/no
Publication of NO307514B1 publication Critical patent/NO307514B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO953931A 1994-10-04 1995-10-03 Chinolon- og naftyridonkarboksylsyrederivater, anvendelse derav samt legemidler inneholdende forbindelsene NO307514B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4435479A DE4435479A1 (de) 1994-10-04 1994-10-04 Chinolon- und Naphthyridoncarbonsäure-Derivate

Publications (3)

Publication Number Publication Date
NO953931D0 NO953931D0 (no) 1995-10-03
NO953931L true NO953931L (no) 1996-04-09
NO307514B1 NO307514B1 (no) 2000-04-17

Family

ID=6529941

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953931A NO307514B1 (no) 1994-10-04 1995-10-03 Chinolon- og naftyridonkarboksylsyrederivater, anvendelse derav samt legemidler inneholdende forbindelsene

Country Status (40)

Country Link
US (1) US5679689A (no)
EP (1) EP0705828B1 (no)
JP (1) JP3794737B2 (no)
KR (1) KR100371883B1 (no)
CN (1) CN1063747C (no)
AT (1) ATE187171T1 (no)
AU (1) AU697608B2 (no)
BG (1) BG62965B1 (no)
CA (1) CA2159547A1 (no)
CO (1) CO4480031A1 (no)
CU (1) CU22751A3 (no)
CZ (1) CZ291616B6 (no)
DE (2) DE4435479A1 (no)
DK (1) DK0705828T3 (no)
DZ (1) DZ1933A1 (no)
EE (1) EE03443B1 (no)
ES (1) ES2140599T3 (no)
FI (1) FI954680A7 (no)
GR (1) GR3032659T3 (no)
HR (1) HRP950469B1 (no)
HU (1) HUT73429A (no)
IL (2) IL130921A (no)
MA (1) MA23682A1 (no)
MY (1) MY113196A (no)
NO (1) NO307514B1 (no)
NZ (1) NZ280129A (no)
PE (1) PE29698A1 (no)
PL (1) PL182812B1 (no)
PT (1) PT705828E (no)
RO (1) RO115261B1 (no)
RU (1) RU2145604C1 (no)
SG (1) SG38880A1 (no)
SI (1) SI0705828T1 (no)
SK (1) SK280877B6 (no)
SV (1) SV1995000063A (no)
TN (1) TNSN95099A1 (no)
TW (1) TW364908B (no)
UA (1) UA42797C2 (no)
YU (1) YU63595A (no)
ZA (1) ZA958296B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US8163769B2 (en) * 2002-03-12 2012-04-24 Abbott Laboratories Antibacterial compounds
EP1631570A1 (en) * 2003-03-12 2006-03-08 Abbott Laboratories Naphthyridine derivatives as antibacterial agents
RU2443698C2 (ru) 2007-01-05 2012-02-27 Дайити Санкио Компани, Лимитед Конденсированное замещенное производное аминопирролидина
MX2022006466A (es) 2019-11-28 2022-08-17 Bayer Ag Aminoquinolonas sustituidas como inhibidores de dgk alfa para la activacion inmune.
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA2030217A1 (en) * 1989-11-21 1991-05-22 Jun Imose Pyridone-carboxylic acid derivatives useful as veterinary medicines
JPH03181478A (ja) * 1989-12-08 1991-08-07 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
JPH04253973A (ja) 1990-04-20 1992-09-09 Banyu Pharmaceut Co Ltd ピリドンカルボン酸誘導体
WO1992012146A1 (en) * 1990-12-27 1992-07-23 Banyu Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivative
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4230804A1 (de) * 1992-09-15 1994-03-17 Bayer Ag 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate
DE4329600A1 (de) 1993-09-02 1995-03-09 Bayer Ag Pyrido [1,2,3-d,e] [1,3,4] benzoxadiazinderivate
ATE216993T1 (de) * 1994-02-04 2002-05-15 Dainippon Pharmaceutical Co Pyridoncarbonsäurederivate substituiert von bicyclischer aminogruppe, deren ester und salze, und bicyclisches amin als zwischenprodukt davon
DE4435479A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Chinolon- und Naphthyridoncarbonsäure-Derivate

Also Published As

Publication number Publication date
PL310747A1 (en) 1996-04-15
SG38880A1 (en) 1997-04-17
EP0705828A1 (de) 1996-04-10
CO4480031A1 (es) 1997-07-09
DZ1933A1 (fr) 2002-02-17
UA42797C2 (uk) 2001-11-15
CU22751A3 (es) 2002-02-28
ES2140599T3 (es) 2000-03-01
KR960014118A (ko) 1996-05-22
SV1995000063A (es) 1996-07-24
HU9502888D0 (en) 1995-11-28
SK123895A3 (en) 1996-06-05
CZ256895A3 (en) 1996-04-17
EE03443B1 (et) 2001-06-15
HUT73429A (en) 1996-07-29
ZA958296B (en) 1996-05-07
NO953931D0 (no) 1995-10-03
DE59507324D1 (de) 2000-01-05
BG100041A (bg) 1996-05-31
PL182812B1 (pl) 2002-03-29
CZ291616B6 (cs) 2003-04-16
AU697608B2 (en) 1998-10-15
CN1126211A (zh) 1996-07-10
EE9500069A (et) 1996-04-15
SK280877B6 (sk) 2000-08-14
EP0705828B1 (de) 1999-12-01
FI954680L (fi) 1996-04-05
JP3794737B2 (ja) 2006-07-12
SI0705828T1 (en) 2000-02-29
DE4435479A1 (de) 1996-04-11
GR3032659T3 (en) 2000-06-30
IL115492A0 (en) 1996-01-19
PT705828E (pt) 2000-04-28
TNSN95099A1 (fr) 1996-02-06
FI954680A0 (fi) 1995-10-02
BG62965B1 (bg) 2000-12-29
RO115261B1 (ro) 1999-12-30
US5679689A (en) 1997-10-21
NO307514B1 (no) 2000-04-17
TW364908B (en) 1999-07-21
HRP950469B1 (en) 2000-12-31
JPH08225567A (ja) 1996-09-03
MY113196A (en) 2001-12-31
IL115492A (en) 1999-12-22
AU3291995A (en) 1996-04-18
DK0705828T3 (da) 2000-05-15
MA23682A1 (fr) 1996-07-01
ATE187171T1 (de) 1999-12-15
CN1063747C (zh) 2001-03-28
YU63595A (sh) 1998-08-14
RU2145604C1 (ru) 2000-02-20
IL130921A (en) 2001-10-31
CA2159547A1 (en) 1996-04-05
FI954680A7 (fi) 1996-04-05
HRP950469A2 (en) 1997-08-31
NZ280129A (en) 1996-06-25
PE29698A1 (es) 1998-08-27
KR100371883B1 (ko) 2003-03-29

Similar Documents

Publication Publication Date Title
AU576302B2 (en) Bridged diazabicycloalkyl quinolone carboxylic acids
KR930016421A (ko) 퀴놀론- 및 나프티리돈-카르복실산 유도체
NO953931D0 (no) Chinolon- og naftyridonkarboksylsyrederivater
DE3778559D1 (de) Thieno-1,4-diazepine.
FI104077B (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatso£1,2-a|(pyrrolo-, tieno- tai furano)£3,2-d|atsepiinijohdannaisten valmistamiseksi ja välituote
PL343540A1 (en) Novel 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4': 6,7]naphto[2,3-d][1,3]dioxol-6(5ah)-one compounds, method of obtaining them and pharmacological compositions containing such compounds
ATE206712T1 (de) 1,9-überbrückte thiazolo(3,2-a)chinolinderivate
GR3018746T3 (en) 2-(4-Piperidinyl)-1H-pyrido[4,3-b]indol-1 ones and related compounds, intermediates and a process for their preparation
DK0721948T3 (da) Quinolon- og naphthyridoncarboxylsyrederivater somantibakterielle midler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees